High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity!

Table 1SARS-CoV-2 seroprevalence in South American populations.

95% CI, 95% confidence interval; ELISA, enzyme-linked immunosorbent assay; LFIA, lateral flow immunoassay.

Figar S, Pagotto V, Luna L, Salto J, Manslau MW, Mistchenko AS, et al. Community-level SARS-CoV-2 Seroprevalence Survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research. medRxiv 2020: 2020.07.14.20153858.

Huamani C, Velásquez L, Montes S, Mayanga-Herrera A, Bernabé-Ortiz A. Population-Based Seroprevalence of SARS-CoV-2 Antibodies in a High-Altitude Setting in Peru. SSRN 2020: 3760458 doi 10.2139/ssrn.3760458

留言 (0)

沒有登入
gif